WO2012145555A3 - Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof - Google Patents

Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof Download PDF

Info

Publication number
WO2012145555A3
WO2012145555A3 PCT/US2012/034316 US2012034316W WO2012145555A3 WO 2012145555 A3 WO2012145555 A3 WO 2012145555A3 US 2012034316 W US2012034316 W US 2012034316W WO 2012145555 A3 WO2012145555 A3 WO 2012145555A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery device
methods
transdermal delivery
delivery devices
producing substances
Prior art date
Application number
PCT/US2012/034316
Other languages
French (fr)
Other versions
WO2012145555A2 (en
Inventor
Norbert Kiss
Original Assignee
Invisiderm, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/033060 external-priority patent/WO2012144990A1/en
Priority to CA2833851A priority Critical patent/CA2833851A1/en
Priority to MX2013012205A priority patent/MX2013012205A/en
Priority to KR1020137030605A priority patent/KR20140035378A/en
Priority to US14/112,896 priority patent/US10130800B2/en
Priority to AU2012245373A priority patent/AU2012245373A1/en
Priority to RU2013151160/14A priority patent/RU2013151160A/en
Priority to CN201280030260.2A priority patent/CN103648576A/en
Application filed by Invisiderm, Llc filed Critical Invisiderm, Llc
Priority to JP2014506557A priority patent/JP2014515666A/en
Priority to SG2013077706A priority patent/SG194215A1/en
Priority to EP12774807.7A priority patent/EP2699306A4/en
Priority to BR112013027006A priority patent/BR112013027006A2/en
Publication of WO2012145555A2 publication Critical patent/WO2012145555A2/en
Publication of WO2012145555A3 publication Critical patent/WO2012145555A3/en
Priority to IL228970A priority patent/IL228970A0/en
Priority to ZA2013/07980A priority patent/ZA201307980B/en
Priority to US16/193,832 priority patent/US20190091454A1/en
Priority to US17/412,063 priority patent/US20210379347A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8218—Gas operated
    • A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/30—Gas therapy for therapeutic treatment of the skin

Abstract

The present specification disclosed a noninvasive transdermal delivery device that relates generally to a handheld mechanical apparatus for noninvasive transdermal administration of gas, small to large water-soluble (hydrophilic) pharmaceutical agents, vitamins, and other therapeutic agents. Components of such delivery devices, methods of producing a substance comprising a supersaturated amount of a dissolved gas, as well as, methods of administering a therapeutic agent using such delivery devices and methods of treating a disease or condition using such delivery devices are also disclosed.
PCT/US2012/034316 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof WO2012145555A2 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP2014506557A JP2014515666A (en) 2011-04-19 2012-04-19 Method for producing a substance with a supersaturated gas, transdermal delivery device and use thereof
SG2013077706A SG194215A1 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
MX2013012205A MX2013012205A (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof.
EP12774807.7A EP2699306A4 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
AU2012245373A AU2012245373A1 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
RU2013151160/14A RU2013151160A (en) 2011-04-19 2012-04-19 METHOD FOR CREATING SUBSTANCES THAT OVERSATURATED WITH GAS, DEVICE FOR TRANSDERMAL DELIVERY AND ITS USE
CN201280030260.2A CN103648576A (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
CA2833851A CA2833851A1 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
BR112013027006A BR112013027006A2 (en) 2011-04-19 2012-04-19 method of producing substances with supersaturated gas, transdermal delivery device thereof
KR1020137030605A KR20140035378A (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas??transdermal delivery device thereof??and uses thereof
US14/112,896 US10130800B2 (en) 2012-01-27 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
IL228970A IL228970A0 (en) 2011-04-19 2013-10-20 Method of producing substances with supersaturated gas,transdermal delivery device thereof ,and uses thereof
ZA2013/07980A ZA201307980B (en) 2011-04-19 2013-10-24 Method of producing substances with supersaturated gas,transdermal delivery device thereof and uses thereof
US16/193,832 US20190091454A1 (en) 2012-01-27 2018-11-16 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US17/412,063 US20210379347A1 (en) 2012-01-27 2021-08-25 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USPCT/US2011/033060 2011-04-19
PCT/US2011/033060 WO2012144990A1 (en) 2011-04-19 2011-04-19 Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof
US201261591443P 2012-01-27 2012-01-27
US61/591,443 2012-01-27

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/112,896 A-371-Of-International US10130800B2 (en) 2012-01-27 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US16/193,832 Continuation US20190091454A1 (en) 2012-01-27 2018-11-16 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Publications (2)

Publication Number Publication Date
WO2012145555A2 WO2012145555A2 (en) 2012-10-26
WO2012145555A3 true WO2012145555A3 (en) 2013-01-17

Family

ID=47042166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/034316 WO2012145555A2 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Country Status (13)

Country Link
EP (1) EP2699306A4 (en)
JP (1) JP2014515666A (en)
KR (1) KR20140035378A (en)
CN (1) CN103648576A (en)
AU (1) AU2012245373A1 (en)
BR (1) BR112013027006A2 (en)
CA (1) CA2833851A1 (en)
IL (1) IL228970A0 (en)
MX (1) MX2013012205A (en)
RU (1) RU2013151160A (en)
SG (1) SG194215A1 (en)
WO (1) WO2012145555A2 (en)
ZA (1) ZA201307980B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US10039910B2 (en) * 2014-03-26 2018-08-07 Nanomed Skincare, Inc. Plumber-like mass transport device for dermal and transdermal delivery of a liquid or solid composition
WO2017136087A1 (en) * 2016-02-05 2017-08-10 Clover Hill Heal Thealthcare, Inc. Nasal treatment delivery device with carbon dioxide and saline, and methods, including low flow rates

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851544A (en) * 1997-12-18 1998-12-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
US20020040205A1 (en) * 2000-02-28 2002-04-04 Rasor Ned S. Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
US20040087916A1 (en) * 2001-09-28 2004-05-06 Pickup Ray L. Cutaneous administration system
US20080058709A1 (en) * 2006-08-31 2008-03-06 Da Silva Freitas Mario A Method and apparatus that associate the parenteral injection of medical grade carbon dioxide (co2) concomitantly with the application of infrared radiation from thermal and/or light sources using control by means of cutaneous and/or body thermometry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20221228U1 (en) * 2002-11-12 2005-07-07 Bode, Lothar Device used for applying substances under pressure to skin comprises main component with pressure medium container, controllable stop valve, pressure reducer and nozzle
US7857167B1 (en) * 2005-08-29 2010-12-28 Anthony Scott Hollars Compressed gas cartridge permeation dispenser having a predictable permeation rate
AU2008354370B2 (en) * 2008-04-09 2014-08-28 Respiderm Corporation Mobile apparatus for the dispersion and transdermal delivery of pharmaceutical, medical or purified carbon dioxide gas
EP2246028A4 (en) * 2008-12-26 2012-08-22 Nakamura Shoichi Pressurized carbon dioxide mist bathing system
US8118777B2 (en) * 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102470068A (en) * 2009-07-14 2012-05-23 艾缪思有限公司 Device for percutaneous absorption of carbon dioxide gas, method for percutaneous absorption of carbon dioxide gas, and envelope

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851544A (en) * 1997-12-18 1998-12-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
US20020040205A1 (en) * 2000-02-28 2002-04-04 Rasor Ned S. Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
US20040087916A1 (en) * 2001-09-28 2004-05-06 Pickup Ray L. Cutaneous administration system
US20080058709A1 (en) * 2006-08-31 2008-03-06 Da Silva Freitas Mario A Method and apparatus that associate the parenteral injection of medical grade carbon dioxide (co2) concomitantly with the application of infrared radiation from thermal and/or light sources using control by means of cutaneous and/or body thermometry

Also Published As

Publication number Publication date
RU2013151160A (en) 2015-05-27
EP2699306A2 (en) 2014-02-26
WO2012145555A2 (en) 2012-10-26
CA2833851A1 (en) 2012-10-26
MX2013012205A (en) 2014-05-28
KR20140035378A (en) 2014-03-21
EP2699306A4 (en) 2016-07-27
IL228970A0 (en) 2013-12-31
SG194215A1 (en) 2013-11-29
BR112013027006A2 (en) 2016-12-27
CN103648576A (en) 2014-03-19
JP2014515666A (en) 2014-07-03
ZA201307980B (en) 2014-06-25
AU2012245373A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
MX2013012206A (en) Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof.
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2011163594A3 (en) Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
WO2011140274A3 (en) Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
MX362626B (en) Methods of treating pediatric patients using dexmedetomidine.
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
MX2009013574A (en) Modified release solid or semi-solid dosage forms.
WO2007117509A8 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
WO2013138702A3 (en) Methods for predicting gastrointestinal immune - related adverse events (gi-irae) in patients treated with co - stimulatory pathway modulators
WO2014036556A3 (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
MX365688B (en) Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin.
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
MY157187A (en) Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2013138628A3 (en) Injectable ibuprofen formulation
CO7101247A2 (en) Polyinosinic-polycytidyl acid (poly (i: c)) formulations for the treatment of upper respiratory infections
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
WO2012145554A3 (en) Method of producing substances with supersaturated gas,transdermal delivery device thereof, and uses thereof
EP3970729A3 (en) Methods of administering high concentrations of nitric oxide
WO2008051527A3 (en) Sustained release of agents for localized pain management
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
WO2012145555A3 (en) Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12774807

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014506557

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2833851

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14112896

Country of ref document: US

Ref document number: MX/A/2013/012205

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2012245373

Country of ref document: AU

Date of ref document: 20120419

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012774807

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013151160

Country of ref document: RU

Kind code of ref document: A

Ref document number: 20137030605

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013027006

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013027006

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131018